Cellular adoptive immunotherapy after allogeneic stem cell transplantation
Authors:
- Anton V.M.B. SchattenbergASAnton V.M.B. Schattenberg
- Harry DolstraHDHarry Dolstra
- 1 November 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 17 (6) , 617-621
Abstract
This review presents the role of donor lymphocyte infusion, natural killer cells, and dendritic cells in cellular immunotherapy after allogeneic stem cell transplantation. It becomes increasingly possible to infuse more specialized subsets of lymphocyte cells after transplantation. The infusion of natural killer cells, especially in non human leukocyte antigen-identical transplantation, may become an important tool in enhancing the graft-versus-tumor effect. Vaccination of patients after stem cell transplantation with autologous-derived dendritic cells merits further investigation. Stem cell transplantation has evolved to a specialized form of immunotherapy.Keywords
This publication has 46 references indexed in Scilit:
- CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot studyBone Marrow Transplantation, 2004
- Donor Lymphocyte Infusions for Patients who Relapse After Allogeneic Stem Cell Transplantation for Chronic Myeloid LeukaemiaLeukemia & Lymphoma, 2003
- IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primatesBlood, 2002
- Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplantsBlood, 2002
- Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen–presenting cellsBlood, 2002
- The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantationBlood, 2002
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantationThe Lancet, 1999
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986